Questo sito o gli strumenti terzi da questo utilizzati si avvalgono di cookie necessari al funzionamento ed utili alle finalità illustrate nella cookie policy. Se vuoi saperne di più o negare il consenso a tutti o ad alcuni cookie, consulta la Cookie Policy.

RT  ASL NAPOLI 3 SUD 

REGISTRO TUMORI DI POPOLAZIONE REGIONE CAMPANIA C/O ASL NAPOLI 3 SUD


  •  Oncology Cancer Network Registration
    Oncology Cancer Network Registration
  • ASL Napoli 3 Cancer Registry Data
    ASL Napoli 3 Cancer Registry Data
  • Health district data
    Health district data

Annalisa Trama, Laura Botta, Nicola Nicolai, Paolo Giorgi Rossi, Paolo Contiero, Mario Fusco, Michele Lodde, Fabio Pannozzo, Silvano Piffer, Antonella Puppo, Andreas Seeber, Rosario Tumino, Riccardo Valdagni, Gemma Gatta, the Prostate Cancer High Resolution Study Working Group.

European Journal of Cancer 67 (2016) 91e 98. doi: 10.1016/j.ejca.2016.07.021.

ABSTRACT

INTRODUCTION:

The incidence of prostate cancer is on the rise in many industrialised countries, including Italy, most likely because of the spread of PSA testing. In Italy, prostate cancer mortality has been dropping since 2000, but it is difficult to understand whether PSA testing is the main reason, considering the role of treatment in prognosis. The objectives of this study were: (1) to describe Italian trends of prostate cancer risk categories and corresponding changes in treatment patterns and (2) to interpret changes in survival over time.

 

METHODS:

We made a retrospective observational study using population-based cancer registries. We examined two periods, 1996-1999 and 2005-2007, analysing the distribution of patients among risk groups and treatment changes in those intervals. We estimated 7- and 15-year relative survival with the cohort approach, Ederer II method. We analysed 4635 cases.

 

RESULTS:

There was downward risk migration from the first to the second period. In patients younger than 75 years, there was an increase in radical prostatectomy but not radiotherapy; patients older than 75 years rarely had treatment with radical intent. We noted an improvement of prostate cancer survival in the high-risk group.

 

CONCLUSION:

These findings raise several questions: the possible overtreatment of low-risk patients undergoing radical treatment; the utility of more aggressive treatment for elderly patients with high-risk disease; and the importance of a multidisciplinary clinical approach to ensure multiple and alternative treatment options. The increase in survival, with the decrease in mortality, suggests an effect of radical treatments on prognosis.

Registro tumori ASL Napoli 3 sud


 

Rete di Registrazione Oncologica Campana

 READ MORE

 

Data Processing

Napoli 3 Sud Cancer Registry Data


 

 

I dati relativi alle principali neoplasie nella ASL Napoli 3 Sud aggiornati al 2021. Sono presenti statistiche relative all’incidenza, alla mortalità e alla sopravvivenza dei tumori per sede neoplastica, sesso e fasce di età. 

   View stats
                               

Tumor Site Data


 

 

Dati di incidenza per le principali neoplasie. Confronto per sesso e fasce di età, trend di incidenza, confronto tra i distretti, rischio cumulativo. Sedi tumorali: mammella, prostata, colon retto, polmone, stomaco, rene e vie urinarie,  tiroide, melanoma, vescica, collo dell’utero e corpo,.. 

   View stats
                               

 Scientific Activities  

Publications, conferences


VIEW ALL

Projects


VIEW ALL